TrialCardiovascular and interventional radiology2022

Randomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Amenable to Curative Treatment.

Josep M Llovet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.